FDA’s clinical trial diversity guidance carries new message from Trump administration
While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page its housed on now carries a message from the Trump administration that the guidance “does not reflect biological reality.”
While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page its housed on now carries a message from the Trump administration that the guidance “does not reflect biological reality.”
